In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the role of neoadjuvant therapy for stage III NSCLC using a virtual tumor board format. This area has become increasingly complex of late, as clinicians have seen several large studies report encouraging results with peri-operative immunotherapy and targeted therapy.

Podcast Hosts:

• Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, USA 

Podcast Guests: 

• Jair Bar, MD, Head of Thoracic Oncology and Deputy Director, Institute of Oncology at Sheba Medical Center; Assocate Professor of Oncology at the School of Medicine, Tel Aviv University, Isreal
• Linda Martin, MD, Chief of Thoracic Surgery & Associate Professor, University of Virginia, USA